The Challenge of Studying Long COVID: An Updated Review
- 8 April 2022
- journal article
- review article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 41 (5) , 424-426
Abstract
Accurately determining the risk of long COVID is challenging. Existing studies in children and adolescents have considerable limitations and distinguishing long-term SARS-CoV-2 infection-associated symptoms from pandemic-related symptoms is difficult. Over half of individuals in this age group, irrespective of COVID-19, report physical and psychologic symptoms, highlighting the impact of the pandemic. More robust data is needed to inform policy decisions.Keywords
This publication has 34 references indexed in Scilit:
- Post-acute COVID-19 outcomes in children with mild and asymptomatic diseaseThe Lancet Child & Adolescent Health, 2021
- Preliminary evidence on long COVID in childrenActa Paediatrica, 2021
- Long‐term symptoms of COVID‐19 in childrenActa Paediatrica, 2021
- The comprehensive clinic, laboratory, and instrumental evaluation of children with COVID‐19: A 6‐months prospective studyJournal of Medical Virology, 2021
- Smell Status in Children Infected with SARS‐CoV‐2The Laryngoscope, 2021
- Persistent clinical features in paediatric patients after SARS-CoV-2 virological recovery: a retrospective population-based cohort study from a single centre in LatviaBMJ Paediatrics Open, 2020
- Long COVID in the Faroe Islands: A Longitudinal Study Among Nonhospitalized PatientsClinical Infectious Diseases, 2020
- Case report and systematic review suggest that children may experience similar long‐term effects to adults after clinical COVID‐19Acta Paediatrica, 2020
- Sequelae of COVID-19 in Hospitalized Children: A 4-Months Follow-UpThe Pediatric Infectious Disease Journal, 2020
- Coronavirus Infections in Children Including COVID-19The Pediatric Infectious Disease Journal, 2020